Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2014; 20(3): 665-672
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.665
Table 1 Recommended first-line therapies for Helicobacter pylori infections
TreatmentDaysNo. of patientsMethods of evaluating eradicationEradication rate % (ITT)Eradication rate % (PP)Adverse effects %Ref.Type of study
Low clarithromycin resistance area (< 20%)PPI (standard dose, bid) + amoxicillin (1 g, bid) + clarithromycin (500 mg, bid)7-101975UBT or H or ROverall77.3-1000-33Mégraud et al[26]Meta-analysis
PPI (standard dose, bid) + amoxicillin (1 g, bid) followed by a triple therapy with a PPI (standard dose, bid) + clarithromycin (500 mg, bid) + metronidazole/tinidazole (500 mg, bid)5 + 55666UBT or H or ROverall 84.30-44Gatta et al[35]Meta-analysis
High clarithromycin resistance area (≥ 20%)PPI (standard dose, bid) + amoxicillin (1 g, bid) + levofloxacin (250 mg, bid)7-10900UBT or H or ROverall72-960-52Berning et al[32]Meta-analysis
PPI (standard dose, bid) + amoxicillin (1 g, bid) followed by a triple therapy with a PPI (standard dose, bid) + levofloxacin (250/500 mg, bid) + tinidazole (500 mg, bid).5 + 5250UBT96/96.898.3/98.422.1-23.5Romano et al[46]RCT
PPI (standard dose, bid) + amoxicillin (1 g, bid) + clarithromycin (500 mg, bid) + metronidazole (500 mg, bid)5135UBT91.491.435.6Kim et al[54]RCT
PPI (high dose, bid) + amoxicillin (1 g, bid) + levofloxacin (500 mg, bid) + tinidazole (500 mg, bid)590UBT92.296.527.8Federico et al[47]RCT
PPI (standard dose, bid) + metronidazole (500 mg, bid) + bismuth (120 mg, q.i.d.) + tetracycline (500 mg, q.i.d.)10218UBT929447Malfertheiner et al[18]RCT
PPI (high dose, bid) + amoxicillin (1 g, bid) followed by a quadruple therapy with a PPI (high dose, bid) + amoxicillin (1 g, bid) + clarithromycin (500 mg, bid) + metronidazole (500 mg, bid)7 + 7171UBT909247Molina-Infante et al[66]RCT